Table 2.
Hemodynamic Variables and Vasopressors/Inotropics in the Course of Disease in Outcome Groups
| Survivors | Non-survivors | P | ||
|---|---|---|---|---|
| n = 11 | n = 9 | |||
| HR, beats/min | I | 118 (105–150) | 126 (97–143) | 0.73 |
| H | 120 (105–176) | 130 (100–159) | 0.91 | |
| L | 100 (68–133) | 116 (90–130) | 0.23 | |
| F | 107 (61–133) | 130 (90–146) | 0.22 | |
| MAP, mmHg | I | 70 (53–100) | 63 (49–82) | 0.27 |
| H | 90 (76–100) | 80 (49–96) | 0.14 | |
| L | 58 (46–80) | 56 (42–72) | 0.34 | |
| F | 76 (70–91) | 56 (42–91) | 0.03 | |
| CVP, mmHg | I | 8 (4–13) | 9 (4–18) | 0.30 |
| H | 11 (6–15) | 17 (11–21) | 0.003 | |
| L | 5 (4–8) | 7 (2–18) | 0.76 | |
| F | 7 (5–15) | 12 (5–22) | 0.03 | |
| CI, L/min/m2 | I | 4.2 (2.1–6.2) | 3.4 (1.8–7.2) | 0.90 |
| H | 4.6 (3.0–6.6) | 3.5 (2.4–7.2) | 0.56 | |
| L | 1.6 (2.1–5.2) | 2.6 (1.5–6.8) | 0.52 | |
| F | 3.7 (2–6) | 3.2 (2.0–6.8) | 0.52 | |
| Lactate, mmol/L | I | 1.7 (1.0–5.1) | 2.6 (0.9–10.0) | <0.001 |
| H | 2.0 (1.3–5.1) | 3.5 (1.1–11.6) | 0.14 | |
| L | 1.0 (0.7–2.0) | 1.9 (0.7–10.0) | 0.05 | |
| F | 1.1 (0.9–2.0) | 2.4 (1.0–11.6) | 0.01 | |
Median (range) and Mann–Whitney U test
HR heart rate (beats per minute), MAP mean arterial pressure, CVP central venous pressure, CI cardiac index. I initial, H highest, L lowest, F final values in the course of time